Sensory disturbances, inhibitory deficits, and the P50 wave in schizophrenia

Neuropsychiatric Disease and Treatment

Volumn 10, Issue , 2014, Pages 1309-1315

  Vlcek, Premysl ^a   Bob, Petr ^a,b   Raboch, Jiri ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Event related potential; Information overload; Inhibition; P50 wave; Schizophrenia; Splitting

Indexed keywords

4 AMINOBUTYRIC ACID; NEUROLEPTIC AGENT;

4 AMINOBUTYRIC ACID RELEASE; ATTENTION DISTURBANCE; EVENT RELATED POTENTIAL; EVOKED RESPONSE; EXCITATORY POSTSYNAPTIC POTENTIAL; FRONTAL CORTEX; FRONTAL LOBE; GABAERGIC SYSTEM; HABITUATION; HUMAN; INTERNEURON; NERVE CELL INHIBITION; NEUROLOGIC DISEASE; PERCEPTION DISORDER; REVIEW; SCHIZOPHRENIA; SENSORY DYSFUNCTION; SENSORY GATING; STIMULUS RESPONSE; TEMPORAL LOBE;

EID: 84904431874     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S64219     Document Type: Review

References (130)

1. McGhie A, Chapman J. Disorders of attention and perception in early schizophrenia. Br J Med Psychol. 1961; 34: 103-116.
2. Venables PH. Input dysfunction in schizophrenia. Prog Exp Pers Res. 1964; 72: 1-47.
3. Saccuzzo DP, Braff DL. Early information processing deficit in schizophrenia. New findings using schizophrenic subgroups and manic control subjects. Arch Gen Psychiatry. 1981; 38: 175-179.
4. Johnson JD. A mechanism to inhibit input activation and its dysfunction in schizophrenia. Br J Psychiatry. 1985; 146: 429-435.
5. Freedman R, Adler LE, Gerhardt GA, et al. Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull. 1987; 13: 669-678.
6. Freedman R, Adler LE, Olincy A, et al. Input dysfunction, schizotypy, and genetic models of schizophrenia. Schizophr Res. 2002; 54: 25-32.
7. Freedman R, Olincy A, Ross RG, et al. The genetics of sensory gating deficits in schizophrenia. Curr Psychiatry Rep. 2003; 5: 155-161.
8. Patterson JV, Hetrick WP, Boutros NN, et al. P50 sensory gating ratios in schizophrenics and controls: a review and data analysis. Psychiatry Res. 2008; 158: 226-247.
9. Olincy A, Braff DL, Adler LE, et al. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res. 2010; 119: 175-182.
10. Siegel C, Waldo M, Mizner G, et al. Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses. Arch Gen Psychiatry. 1984; 41: 607-612.
11. Bramon E, Rabe-Hesketh S, Sham P, et al. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res. 2004; 70: 315-329.
12. Onitsuka T, Oribe N, Nakamura I, et al. Review of neurophysiological findings in patients with schizophrenia. Psychiatry Clin Neurosci. 2013; 67: 461-470.
13. Brockhaus-Dumke A, Schultze-Lutter F, Mueller R, et al. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Biol Psychiatry. 2008; 64: 376-384.
14. Myles-Worsley M, Ord L, Blailes F, et al. P50 sensory gating in adolescents from a Pacific Island isolate with elevated risk for schizophrenia. Biol Psychiatry. 2004; 55: 663-667.
15. Yee CM, Williams TJ, White PM, et al. Attentional modulation of the P50 suppression deficit in recent-onset and chronic schizophrenia. J Abnorm Psychol. 2010; 119: 31-39.
16. Yee CM, Nuechterlein KH, Morris SE, et al. P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects. J Abnorm Psychol. 1998; 107: 691-698.
17. Adler LE, Olincy A, Waldo M, et al. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull. 1998; 24: 189-202.
18. Cadenhead KS, Light GA, Shafer KM, et al. P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biol Psychiatry. 2005; 57: 1504-1509.
19. Leonard S, Adams C, Breese CR, et al. Nicotinic receptor function in schizophrenia. Schizophr Bull. 1996; 22: 431-445.
20. Freedman R. The Madness Within Us: Schizophrenia as a Neuronal Process. Oxford, UK: Oxford University Press; 2010.
21. Bickford-Wimer PC, Nagamoto H, Johnson R, et al. Auditory sensory gating in hippocampal neurons: a model system in the rat. Biol Psychiatry. 1990; 27: 183-192.
22. Miller CL, Freedman R. Medial septal neuron activity in relation to an auditory sensory gating paradigm. Neuroscience. 1993; 55: 373-380.
23. Luntz-Leybman V, Bickford PC, Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 1992; 587: 130-136.
24. Krause M, Hoffmann WE, Hajos M. Auditory sensory gating in hippocampus and reticular thalamic neurons in anesthetized rats. Biol Psychiatry. 2003; 53: 244-253.
25. Esclapez M, Hirsch JC, Khazipov R, et al. Operative GABAergic inhibition in hippocampal CA1 pyramidal neurons in experimental epilepsy. Proc Natl Acad Sci U S A. 1997; 94: 12151-12156.
26. Seamans JK, Gorelova N, Durstewitz D, et al. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci. 2001; 21: 3628-3638.
27. Homayoun H, Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci. 2007; 27: 11496-11500.
28. Klausberger T, Somogyi P. Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science. 2008; 321: 53-57.
29. Croft RJ, Lee A, Bertolot J, et al. Associations of P50 suppression and desensitization with perceptual and cognitive features of "unreality" in schizotypy. Biol Psychiatry. 2001; 50: 441-446.
30. de Wilde OM, Bour LJ, Dingemans PM, et al. A meta-analysis of P50 studies in patients with schizophrenia and relatives: differences in methodology between research groups. Schizophr Res. 2007; 97: 137-151.
31. Yadon CA, Bugg JM, Kisley MA, et al. P50 sensory gating is related to performance on select tasks of cognitive inhibition. Cogn Affect Behav Neurosci. 2009; 9: 448-458.
32. Moxon KA, Gerhardt GA, Gulinello M, et al. Inhibitory control of sensory gating in a computer model of the CA3 region of the hippocampus. Biol Cybern. 2003; 88: 247-264.
33. Adler LE, Hoffer LJ, Griffith J, et al. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry. 1992; 32: 607-616.
34. Adler LE, Hoffer LD, Wiser A, et al. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry. 1993; 150: 1856-1861.
35. Stevens KE, Freedman R, Collins AC, et al. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology. 1996; 15: 152-162.
36. Freedman R, Coon H, Myles-Worsley M, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A. 1997; 94: 587-592.
37. Griffith JM, O'Neill JE, Petty F, et al. Nicotinic receptor desensitization and sensory gating deficits in schizophrenia. Biol Psychiatry. 1998; 44: 98-106.
38. Stevens KE, Kem WR, Mahnir VM, et al. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology (Berl). 1998; 136: 320-327.
39. Leonard S, Gault J, Hopkins J, et al. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry. 2002; 59: 1085-1096.
40. Martin LF, Freedman R. Schizophrenia and the alpha7 nicotinic acetylcholine receptor. Int Rev Neurobiol. 2007; 78: 225-246.
41. Martin LF, Kem WR, Freedman R. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl). 2004; 174: 54-64.
42. Brinkman MJ, Stauder JE. Development and gender in the P50 paradigm. Clin Neurophysiol. 2007; 118: 1517-1524.
43. Young JW, Geyer MA. Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia. Biochem Pharmacol. 2013; 86: 1122-1132.
44. Freedman R. alpha7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia. Annu Rev Med. 2014; 65: 245-261.
45. Baker NJ, Staunton M, Adler LE, et al. Sensory gating deficits in psychiatric inpatients: relation to catecholamine metabolites in different diagnostic groups. Biol Psychiatry. 1990; 27: 519-528.
46. Waldo M, Gerhardt G, Baker N, et al. Auditory sensory gating and catecholamine metabolism in schizophrenic and normal subjects. Psychiatry Res. 1992; 44: 21-32.
47. Adler LE, Hoffer L, Nagamoto HT, et al. Yohimbine impairs P50 auditory sensory gating in normal subjects. Neuropsychopharmacology. 1994; 10: 249-257.
48. Hammer TB, Oranje B, Glenthoj BY. The effects of imipramine on P50 suppression, prepulse inhibition and habituation of the startle response in humans. Int J Neuropsychopharmacol. 2007; 10: 787-795.
49. Oranje B, Glenthoj BY. Clonidine normalizes levels of P50 gating in patients with schizophrenia on stable medication. Schizophr Bull. Epub 2013 October 8.
50. Galazyuk AV, Feng AS. Encoding of sound duration by neurons in the auditory cortex of the little brown bat, Myotis lucifugus. J Comp Physiol A. 1997; 180: 301-311.
51. Tan AY, Zhang LI, Merzenich MM, et al. Tone-evoked excitatory and inhibitory synaptic conductances of primary auditory cortex neurons. J Neurophysiol. 2004; 92: 630-643.
52. Wehr M, Zador AM. Synaptic mechanisms of forward suppression in rat auditory cortex. Neuron. 2005; 47: 437-445.
53. Fritz J, Shamma S, Elhilali M. One click, two clicks: the past shapes the future in auditory cortex. Neuron. 2005; 47: 325-327.
54. Smith DM, Grant B, Fisher DJ, et al. Auditory verbal hallucinations in schizophrenia correlate with P50 gating. Clin Neurophysiol. 2013; 124: 1329-1335.
55. Miller CL, Freedman R. The activity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli. Neuroscience. 1995; 69: 371-381.
56. Mears RP, Klein AC, Cromwell HC. Auditory inhibitory gating in medial prefrontal cortex: single unit and local field potential analysis. Neuroscience. 2006; 141: 47-65.
57. Volkov IO, Galazyuk AV. Peculiarities of inhibition in cat auditory cortex neurons evoked by tonal stimuli of various durations. Exp Brain Res. 1992; 91: 115-120.
58. Merzenich MM, Schreiner C, Jenkins W, et al. Neural mechanisms underlying temporal integration, segmentation, and input sequence representation: some implications for the origin of learning disabilities. Ann N Y Acad Sci. 1993; 682: 1-22.
59. Wehr M, Zador AM. Balanced inhibition underlies tuning and sharpens spike timing in auditory cortex. Nature. 2003; 426: 442-446.
60. Freedman R, Waldo M, Bickford-Wimer P, et al. Elementary neuronal dysfunctions in schizophrenia. Schizophr Res. 1991; 4: 233-243.
61. Freedman R, Adler LE, Myles-Worsley M, et al. Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model. Arch Gen Psychiatry. 1996; 53: 1114-1121.
62. Boutros NN, Belger A. Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating. Biol Psychiatry. 1999; 45: 917-922.
63. Vinogradova OS. Hippocampus as comparator: role of the two input and two output systems of the hippocampus in selection and registration of information. Hippocampus. 2001; 11: 578-598.
64. Sakai M, Chimoto S, Qin L, et al. Neural mechanisms of interstimulus interval-dependent responses in the primary auditory cortex of awake cats. BMC Neurosci. 2009; 10: 10.
65. Du X, Jansen BH. A neural network model of normal and abnormal auditory information processing. Neural Netw. 2011; 24: 568-574.
66. Boutros NN, Gjini K, Eickhoff SB, et al. Mapping repetition suppression of the P50 evoked response to the human cerebral cortex. Clin Neurophysiol. 2013; 124: 675-685.
67. Korzyukov O, Pflieger ME, Wagner M, et al. Generators of the intracranial P50 response in auditory sensory gating. Neuroimage. 2007; 35: 814-826.
68. Simons JS, Spiers HJ. Prefrontal and medial temporal lobe interactions in long-term memory. Nat Rev Neurosci. 2003; 4: 637-648.
69. Geyer MA, Braff DL. Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophr Bull. 1987; 13: 643-668.
70. Duncan CC. Event-related brain potentials: a window on information processing in schizophrenia. Schizophr Bull. 1988; 14: 199-203.
71. Braff DL, Geyer MA. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry. 1990; 47: 181-188.
72. Grillon C, Courchesne E, Ameli R, et al. Increased distractibility in schizophrenic patients. Electrophysiologic and behavioral evidence. Arch Gen Psychiatry. 1990; 47: 171-179.
73. Karper LP, Freeman GK, Grillon C, et al. Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis. J Neuropsychiatry Clin Neurosci. 1996; 8: 60-66.
74. Silverstein SM, Keane BP. Perceptual organization impairment in schizophrenia and associated brain mechanisms: review of research from 2005 to 2010. Schizophr Bull. 2011; 37: 690-699.
75. Rajji TK, Miranda D, Mulsant BH. Cognition, function, and disability in patients with schizophrenia: a review of longitudinal studies. Can J Psychiatry. 2014; 59: 13-17.
76. Shakow D. Psychological deficit in schizophrenia. Behav Sci. 1963; 8: 275-305.
77. Venables PH. Selectivity of attention, withdrawal, and cortical activation. Studies in chronic schizophrenia. Arch Gen Psychiatry. 1963; 9: 74-78.
78. Braff DL, Grillon C, Geyer MA. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry. 1992; 49: 206-215.
79. Hetrick WP, Erickson MA, Smith DA. Phenomenological dimensions of sensory gating. Schizophr Bull. 2012; 38: 178-191.
80. Hu L, Boutros NN, Jansen BH. Sensory gating-out and gating-in in normal and schizophrenic participants. Clin EEG Neurosci. 2012; 43: 23-31.
81. Ji B, Mei W, Zhang JX, et al. Abnormal auditory sensory gating-out in first-episode and never-medicated paranoid schizophrenia patients: an fMRI study. Exp Brain Res. 2013; 229: 139-147.
82. Smucny J, Olincy A, Eichman LC, et al. Early sensory processing deficits predict sensitivity to distraction in schizophrenia. Schizophr Res. 2013; 147: 196-200.
83. Freedman R, Adler LE, Waldo M. Gating of the auditory evoked potential in children and adults. Psychophysiology. 1987; 24: 223-227.
84. Zhang XY, Liu L, Liu S, et al. Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia. Am J Psychiatry. 2012; 169: 974-981.
85. Deutsch SI, Schwartz BL, Schooler NR, et al. Targeting alpha-7 nicotinic neurotransmission in schizophrenia: a novel agonist strategy. Schizophr Res. 2013; 148: 138-144.
86. Hahn B, Gold JM, Buchanan RW. The potential of nicotinic enhancement of cognitive remediation training in schizophrenia. Neuropharmacology. 2013; 64: 185-190.
87. Taly A. Novel approaches to drug design for the treatment of schizophrenia. Expert Opin Drug Discov. 2013; 8: 1285-1296.
88. Adler LE, Cawthra EM, Donovan KA, et al. Improved P50 auditory gating with ondansetron in medicated schizophrenia patients. Am J Psychiatry. 2005; 162: 386-388.
89. Koike K, Hashimoto K, Takai N, et al. Tropisetron improves deficits in auditory P50 suppression in schizophrenia. Schizophr Res. 2005; 76: 67-72.
90. Callaway E, 3rd, Jones RT, Layne RS. Evoked responses and segmental set of schizophrenia. Arch Gen Psychiatry. 1965; 12: 83-89.
91. Shakow D. Segmental set. The adaptive process in schizophrenia. Am Psychol. 1977; 32: 129-139.
92. Javitt DC. When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. Annu Rev Clin Psychol. 2009; 5: 249-275.
93. Leitman DI, Sehatpour P, Higgins BA, et al. Sensory deficits and distributed hierarchical dysfunction in schizophrenia. Am J Psychiatry. 2010; 167: 818-827.
94. Williams LE, Blackford JU, Luksik A, et al. Reduced habituation in patients with schizophrenia. Schizophr Res. 2013; 151: 124-132.
95. Adler LE, Pachtman E, Franks RD, et al. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry. 1982; 17: 639-654.
96. Adler LE, Olincy A, Cawthra EM, et al. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Am J Psychiatry. 2004; 161: 1822-1828.
97. Freedman R, Adler LE, Waldo MC, et al. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. Biol Psychiatry. 1983; 18: 537-551.
98. Baker N, Adler LE, Franks RD, et al. Neurophysiological assessment of sensory gating in psychiatric inpatients: comparison between schizophrenia and other diagnoses. Biol Psychiatry. 1987; 22: 603-617.
99. Judd LL, McAdams L, Budnick B, et al. Sensory gating deficits in schizophrenia: new results. Am J Psychiatry. 1992; 149: 488-493.
100. Clementz BA, Blumenfeld LD, Cobb S. The gamma band response may account for poor P50 suppression in schizophrenia. Neuroreport. 1997; 8: 3889-3893.
101. Boutros NN, Belger A, Campbell D, et al. Comparison of four components of sensory gating in schizophrenia and normal subjects: a preliminary report. Psychiatry Res. 1999; 88: 119-130.
102. Boutros NN, Korzyukov O, Jansen B, et al. Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients. Psychiatry Res. 2004; 126: 203-215.
103. Light GA, Geyer MA, Clementz BA, et al. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am J Psychiatry. 2000; 157: 767-771.
104. Patterson JV, Jin Y, Gierczak M, et al. Effects of temporal variability on P50 and the gating ratio in schizophrenia: a frequency domain adaptive filter single-trial analysis. Arch Gen Psychiatry. 2000; 57: 57-64.
105. Myles-Worsley M. P50 sensory gating in multiplex schizophrenia families from a Pacific Island isolate. Am J Psychiatry. 2002; 159: 2007-2012.
106. Hong LE, Summerfelt A, McMahon RP, et al. Gamma/beta oscillation and sensory gating deficit in schizophrenia. Neuroreport. 2004; 15: 155-159.
107. Ringel TM, Heidrich A, Jacob CP, et al. Sensory gating deficit in a subtype of chronic schizophrenic patients. Psychiatry Res. 2004; 125: 237-245.
108. Johannesen JK, Kieffaber PD, O'Donnell BF, et al. Contributions of subtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression in schizophrenia. Schizophr Res. 2005; 78: 269-284.
109. Louchart-de la Chapelle S, Levillain D, Menard JF, et al. P50 inhibitory gating deficit is correlated with the negative symptomatology of schizophrenia. Psychiatry Res. 2005; 136: 27-34.
110. Price GW, Michie PT, Johnston J, et al. A multivariate electrophysiological endophenotype, from a unitary cohort, shows greater research utility than any single feature in the Western Australian family study of schizophrenia. Biol Psychiatry. 2006; 60: 1-10.
111. Thoma RJ, Hanlon FM, Miller GA, et al. Neuropsychological and sensory gating deficits related to remote alcohol abuse history in schizophrenia. J Int Neuropsychol Soc. 2006; 12: 34-44.
112. Jansen BH, Hu L, Boutros NN. Auditory evoked potential variability in healthy and schizophrenia subjects. Clin Neurophysiol. 2010; 121: 1233-1239.
113. Sanchez-Morla EM, Garcia-Jimenez MA, Barabash A, et al. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia. Acta Psychiatr Scand. 2008; 117: 313-318.
114. Devrim-Ucok M, Keskin-Ergen HY, Ucok A. P50 gating at acute and post-acute phases of first-episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32: 1952-1956.
115. Chang WP, Arfken CL, Sangal MP, et al. Probing the relative contribution of the first and second responses to sensory gating indices: a meta-analysis. Psychophysiology. 2011; 48: 980-992.
116. Sanchez-Morla EM, Santos JL, Aparicio A, et al. Neuropsychological correlates of P50 sensory gating in patients with schizophrenia. Schizophr Res. 2013; 143: 102-106.
117. Magnee MJ, Oranje B, van Engeland H, et al. Cross-sensory gating in schizophrenia and autism spectrum disorder: EEG evidence for impaired brain connectivity? Neuropsychologia. 2009; 47: 1728-1732.
118. Traub RD, Whittington MA, Stanford IM, et al. A mechanism for generation of long-range synchronous fast oscillations in the cortex. Nature. 1996; 383: 621-624.
119. Traub RD, Whittington MA, Buhl EH, et al. On the mechanism of the gamma-beta frequency shift in neuronal oscillations induced in rat hippocampal slices by tetanic stimulation. J Neurosci. 1999; 19: 1088-1105.
120. Kopell N, Ermentrout GB, Whittington MA, et al. Gamma rhythms and beta rhythms have different synchronization properties. Proc Natl Acad Sci U S A. 2000; 97: 1867-1872.
121. Bibbig A, Faulkner HJ, Whittington MA, et al. Self-organized synaptic plasticity contributes to the shaping of gamma and beta oscillations in vitro. J Neurosci. 2001; 21: 9053-9067.
122. Haenschel C, Baldeweg T, Croft RJ, et al. Gamma and beta frequency oscillations in response to novel auditory stimuli: a comparison of human electroencephalogram (EEG) data with in vitro models. Proc Natl Acad Sci U S A. 2000; 97: 7645-7650.
123. Engel AK, Fries P, Singer W. Dynamic predictions: oscillations and synchrony in top-down processing. Nat Rev Neurosci. 2001; 2: 704-716.
124. Fries P. A mechanism for cognitive dynamics: neuronal communication through neuronal coherence. Trends Cogn Sci. 2005; 9: 474-480.
125. Fries P, Nikolic D, Singer W. The gamma cycle. Trends Neurosci. 2007; 30: 309-316.
126. Fuchs EC, Doheny H, Faulkner H, et al. Genetically altered AMPA-type glutamate receptor kinetics in interneurons disrupt long-range synchrony of gamma oscillation. Proc Natl Acad Sci U S A. 2001; 98: 3571-3576.
127. Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci. 2005; 6: 312-324.
128. Gonzalez-Burgos G, Lewis DA. GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull. 2008; 34: 944-961.
129. Mulert C, Kirsch V, Pascual-Marqui R, et al. Long-range synchrony of gamma oscillations and auditory hallucination symptoms in schizophrenia. Int J Psychophysiol. 2011; 79: 55-63.
130. McNally JM, McCarley RW, Brown RE. Impaired GABAergic neurotransmission in schizophrenia underlies impairments in cortical gamma band oscillations. Curr Psychiatry Rep. 2013; 15: 346.